Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (43 ops.)
Latest filing published 15 Oct 2026 for Nurix Therapeutics, Inc., €2,409.
Filing timeline
BuySaleGwenn Hansen
Insider track record
Disclosed buys
0
Disclosed sells
43
Signal history
Gwenn Hansen: trading record in brief
Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc., has 108 filings from December 1, 2020 to October 15, 2026, with a median publication delay of 0 days: filings come out on the day of the trade.
The record is 65 option exercises and 43 open-market sales, with no purchase and no grant. The sales total EUR 1,306,639, with a median of EUR 18,111; the largest are EUR 94,951 on June 25, 2026, EUR 94,438 on August 5, 2026 and EUR 78,485 on July 30, 2026, all recent.
Activity is rising: 31 filings in 2021, then 9 in 2022, 10 in 2023, 14 in 2024, 19 in 2025 and 24 in 2026. In the last twelve months there are 29 filings, 11 of them sales. Christine Ring has trades within 30 days of 43 of Gwenn Hansen's trades, Hans van Houte of 28 and Pierre Beaurang of 12, all in the same direction.
Companies and markets linked to Gwenn Hansen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations108 total
1,452 shares@ US$1.860.0001% mcap0.5% of flowCommon StockSEC:0001817160-26-000021:0
1,452 shares@ US$25.000.0014% mcap7.3% of flowCommon StockSEC:0001817160-26-000021:1
1,452 shares@ US$25.470.0015% mcap7.8% of flowCommon StockSEC:0001817160-26-000019:1
1,452 shares@ US$1.860.0001% mcap0.6% of flowCommon StockSEC:0001817160-26-000019:0
1,500 shares@ US$23.86840.0014% mcap7.7% of flowCommon StockSEC:0001817160-26-000015:0
2,611 shares@ US$24.64150.0026% mcap13.8% of flowCommon StockSEC:0001817160-26-000015:1
4,356 shares@ US$1.860.0003% mcap1.7% of flowCommon StockSEC:0001817160-26-000017:0
4,356 shares@ US$25.000.0043% mcap23.3% of flowCommon StockSEC:0001817160-26-000017:1
3,750 shares0Common StockSEC:0001817160-26-000012:0
2,858 shares0Common StockSEC:0001817160-26-000012:1
3,572 shares0Common StockSEC:0001817160-26-000012:2
3,847 shares@ US$23.38280.0036% mcap19.3% of flowCommon StockSEC:0001817160-26-000012:3
5,394 shares@ US$20.0017.7% of flowCommon StockSEC:0001817160-26-000010:0
3,214 shares@ US$16.64530.0021% mcap11.2% of flowCommon StockSEC:0001817160-26-000008:3
2,000 shares0Common StockSEC:0001817160-26-000008:0
3,750 shares0Common StockSEC:0001817160-26-000008:1
2,858 shares0Common StockSEC:0001817160-26-000008:2
31,333 shares@ US$0.845.5% of flowCommon StockSEC:0001817160-26-000004:0
2,000 shares0Common StockSEC:0001817160-26-000002:1
3,750 shares0Common StockSEC:0001817160-26-000002:2
2,859 shares0Common StockSEC:0001817160-26-000002:3
4,797 shares@ US$16.584.7% of flowCommon StockSEC:0001817160-26-000002:4
98 shares@ US$17.370.1% of flowCommon StockSEC:0001817160-26-000002:5
3,207 shares0Common StockSEC:0001817160-26-000002:0
2,000 shares0Common StockSEC:0001817160-25-000005:1
25 of 108 declarations
